Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
批准号:
7755457
负责人:
Pinghui Feng
金额:
$31.39万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-10 至 2014-04-30
关键词:
ApoptosisBiochemicalBiologicalBiological AssayCell DeathCellsComplexDisease ProgressionDominant-Negative MutationEndoplasmic Reticulum Degradation PathwayEukaryotic CellEventG-Protein-Coupled ReceptorsGeneticHerpesviridaeHerpesviridae InfectionsHumanHuman Herpesvirus 8Immunologic Deficiency SyndromesInfectionInflammationKaposi SarcomaLesionLinkLymphomaLyticLytic PhaseMalignant NeoplasmsMammalian CellMediatingMembrane ProteinsMissionMolecularMulticentric Angiofollicular Lymphoid HyperplasiaPapillomaPathogenesisPathway interactionsPatientsPost-Translational RegulationProteinsProteolysisRegulationRetinalRhodopsinRoleRouteSignal TransductionSystemTP53 geneTumorigenicityUbiquitinationViralViral ProteinsViruseffusiongammaherpesvirusgrowth promoting activitylytic replicationmouse modelmulticatalytic endopeptidase complexoverexpressionp97 ATPasepost-doctoral trainingprotein degradationprotein misfoldingpublic health relevanceresearch studytumortumor autocrine motility factor receptortumorigenesistumorigenicubiquitin-protein ligasevirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Post-translational events underlying the pathogenesis of vGPCR Human gamma herpesviruses such as Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) are often associated with infection of immunodeficiency virus-1 and induce tumor in patients. In addition to latent proteins, KSHV lytic proteins have been demonstrated to possess tumorigenic or growth-promoting activities, indicating that lytic replication may contribute to the disease progression of KS and other KSHV-associated malignancies. One intriguing example is the KSHV-encoded G protein-coupled receptor (vGPCR). Although tumorigenicity and signaling events downstream of vGPCR are better defined, it is not clear how vGPCR is regulated. In fact, continuous expression of constitutively active GPCRs (e.g., vGPCR or retinal rhodopsin) induced cell death in mammalian cells, raising the possibility that KSHV has evolved mechanisms to control vGPCR expression and activity. Our preliminary study discovered that the K7 membrane protein interacts with vGPCR and induces its proteasome degradation. Furthermore, K7 retains vGPCR in the ER and increases vGPCR ubiquitination. We hypothesize that K7 induces the ER- associated degradation of vGPCR and functions as a negative regulator for vGPCR tumorigenesis. Our study proposes to elucidate the molecular action of K7 in routing vGPCR to the ER-associated degradation. We will employ both genetic and biochemical assays to identify cellular factors and characterize their roles in K7-induced vGPCR degradation. These experiments not only will elucidate the intracellular regulation of vGPCR, but also will reveal cellular molecules that can be potentially targeted for anti- viral therapy. PUBLIC HEALTH RELEVANCE: Human herpesviruses such as Kaposi's sarcoma-associated herpesvirus (KSHV) induce tumor in patients under conditions of immunodeficiency. KSHV has various gene products that are capable of promoting tumor formation. This study proposes to investigate how one of these viral proteins, the KSHV G protein-coupled receptor, is regulated at the post-translational level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting IKKepsilon-mediated nucleotide synthesis in KSHV-associated lymphoma
-
批准号:10762816
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2023
-
负责人:Pinghui Feng
-
依托单位:
Explore roles of HSV-1 in Alzheimer's disease using mouse models
-
批准号:10629403
-
项目类别:
-
资助金额:$79.9万
-
财政年份:2021
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9752511
-
项目类别:
-
资助金额:$104.23万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Exploring roles of protein deamidation in oral inflammation
-
批准号:9461929
-
项目类别:
-
资助金额:$67.72万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:9410699
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
NFAT activation in kGPCR tumorigenesis
-
批准号:10251852
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2017
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9116597
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
Targeting an immune kinase to purge KSHV latent infection
-
批准号:9242614
-
项目类别:
-
资助金额:$67.66万
-
财政年份:2016
-
负责人:Pinghui Feng
-
依托单位:
A recombinant virus approach for gamma herpesvirus oncogenesis
-
批准号:8638543
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2013
-
负责人:Pinghui Feng
-
依托单位:
Protein Deamidation in Innate Immune Evasion Regulated by Viral Pseudo Enzymes
-
批准号:9381580
-
项目类别:
-
资助金额:$45.48万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8184241
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8846572
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8469753
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Proviral Roles of an Innate Immune Pathway
-
批准号:8326568
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8246529
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8060647
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8460123
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
Post-Translational Events Underlying the KSHV vGPCR Pathogenesis
-
批准号:8367335
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2009
-
负责人:Pinghui Feng
-
依托单位:
INHIBITION OF MITOCHONDRION-DEPENDENT APOPTOSIS BY HERPESVIRAL PROTEIN
-
批准号:7715509
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2008
-
负责人:Pinghui Feng
-
依托单位:
GAMMAHV68 VMAP MITOCHONDRIAL ANTI-APOPTOSIS PROTEIN
-
批准号:7562107
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2007
-
负责人:Pinghui Feng
-
依托单位:
海外基金